Correcting Age-Related Overactive Bladder Syndrome by Inhibiting Matrix Metallopeptidase-9 Overexpression
Description: Overactive bladder syndrome (OAB) is characterized by the loss of bladder control and the frequent urge to urinate, interfering with daily life activities, such as sleep, work and leisure, which reduces the quality of life. OAB affects around 20% of the Canadian adults and increases in prevalence with age. Although the underlying causes of OAB are unknown, a recent study has shown that aging females with OAB exhibit lower levels of a protein, Nerve Growth Factor (NGF), in their urine. NGF is essential for nervous system health. Since the bladder is under strict control of the nervous system, the decrease in NGF reduces the neurological control of the bladder and poor control of urine storage and release. Decreased NGF may be explained by an increased activity of Matrix Metallopeptidase-9 (MMP-9), an enzyme responsible for degrading NGF. MMP-9 activity is regulated by microRNAs, biological molecules that play a role in controlling gene expression. The microRNA, miR-491-5p, inhibits MMP-9 gene expression to prevent NGF degradation. In the urine of aging females with OAB, MMP-9 activity is increased and miR-491-5p levels are reduced, likely explaining the reduced NGF levels. Thus, controlling MMP-9 may restore NGF levels and reverse OAB. Our study aims to inhibit the activity of MMP-9 to correct OAB through administration of miR-491-5p mimics in mouse models of age-related OAB. We hypothesize that miR-591-5p mimics will prevent the synthesis of MMP-9, restoring adequate NGF levels to correct OAB in aging mice. Most of our preliminary data are derived from a cohort of human patients. The clinical implication of this study lies in our assessment of the functional benefit of restoring bladder NGF in aging mice with OAB, which may enable future treatments for age-related OAB.
Amount: CA$17,500
Funding type: fellowship
Funder scheme: Master's Award: Canada Graduate Scholarships
Start date: 2021-05-01
End date: 2022-04-30
Investigator: Aalya Hamouda (lead)
Institution: McGill University
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: 176948_1
OpenAlex ID: G7472299604
